> top > docs > PubMed:18242507 > annotations

PubMed:18242507 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-90 Sentence denotes Unraveling the complexity of endocrine resistance in breast cancer by functional genomics.
TextSentencer_T2 91-232 Sentence denotes Despite the proven benefit of antiestrogen drugs in breast cancer treatment, resistant disease ultimately develops in advanced breast cancer.
TextSentencer_T3 233-437 Sentence denotes In this issue of Cancer Cell, Iorns et al. find that loss of CDK10 expression promotes resistance of cells to tamoxifen and is associated with poor outcome in breast cancer patients treated with the drug.
TextSentencer_T4 438-624 Sentence denotes CDK10 loss increases the activity of the transcription factor ETS2 on the promoter of the RAF1 gene, elevating ERK/MAPK kinase pathway activity and relieving tamoxifen-induced G1 arrest.
TextSentencer_T5 625-753 Sentence denotes CDK10 is thus a potential biomarker for sensitivity in prospective clinical trials of patients treated with endocrine therapies.
T1 0-90 Sentence denotes Unraveling the complexity of endocrine resistance in breast cancer by functional genomics.
T2 91-232 Sentence denotes Despite the proven benefit of antiestrogen drugs in breast cancer treatment, resistant disease ultimately develops in advanced breast cancer.
T3 233-437 Sentence denotes In this issue of Cancer Cell, Iorns et al. find that loss of CDK10 expression promotes resistance of cells to tamoxifen and is associated with poor outcome in breast cancer patients treated with the drug.
T4 438-624 Sentence denotes CDK10 loss increases the activity of the transcription factor ETS2 on the promoter of the RAF1 gene, elevating ERK/MAPK kinase pathway activity and relieving tamoxifen-induced G1 arrest.
T5 625-753 Sentence denotes CDK10 is thus a potential biomarker for sensitivity in prospective clinical trials of patients treated with endocrine therapies.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 294-299 gene:8558 denotes CDK10
T1 392-405 disease:C0006142 denotes breast cancer
T2 294-299 gene:8558 denotes CDK10
T3 392-405 disease:C0678222 denotes breast cancer
R1 T0 T1 associated_with CDK10,breast cancer
R2 T2 T3 associated_with CDK10,breast cancer

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
18242507-2#61#66#gene8558 294-299 gene8558 denotes CDK10
18242507-2#159#172#diseaseC0006142 392-405 diseaseC0006142 denotes breast cancer
18242507-2#159#172#diseaseC0678222 392-405 diseaseC0678222 denotes breast cancer
61#66#gene8558159#172#diseaseC0006142 18242507-2#61#66#gene8558 18242507-2#159#172#diseaseC0006142 associated_with CDK10,breast cancer
61#66#gene8558159#172#diseaseC0678222 18242507-2#61#66#gene8558 18242507-2#159#172#diseaseC0678222 associated_with CDK10,breast cancer

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2220 294-299 gene:8558 denotes CDK10
T2221 392-405 disease:C0006142 denotes breast cancer
R1 T2220 T2221 associated_with CDK10,breast cancer
R2 T2220 T2221 associated_with CDK10,breast cancer

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 53-59 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 143-149 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 218-224 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 392-398 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 53-59 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 143-149 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 218-224 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 392-398 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast